Meike Pauly-Evers
Overview
Explore the profile of Meike Pauly-Evers including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
301
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sahni J, Patel S, Dugel P, Khanani A, Jhaveri C, Wykoff C, et al.
Ophthalmology
. 2019 Mar;
126(8):1155-1170.
PMID: 30905643
Purpose: The phase 2 BOULEVARD trial compared safety and efficacy of faricimab, a novel bispecific antibody targeting angiopoietin-2 and vascular endothelial growth factor-A (VEGF-A), with ranibizumab in patients with diabetic...
2.
Nave S, Doody R, Boada M, Grimmer T, Savola J, Delmar P, et al.
J Alzheimers Dis
. 2017 May;
58(4):1217-1228.
PMID: 28550255
Background: Sembragiline is a potent, selective, long-acting, and reversible MAO-B inhibitor developed as a potential treatment for Alzheimer's disease (AD). Objective: To evaluate the safety, tolerability, and efficacy of sembragiline...
3.
Czikora I, Alli A, Bao H, Kaftan D, Sridhar S, Apell H, et al.
Am J Respir Crit Care Med
. 2014 Jul;
190(5):522-32.
PMID: 25029038
Rationale: Alveolar liquid clearance is regulated by Na(+) uptake through the apically expressed epithelial sodium channel (ENaC) and basolaterally localized Na(+)-K(+)-ATPase in type II alveolar epithelial cells. Dysfunction of these...
4.
Ray K, Ditmarsch M, Kallend D, Niesor E, Suchankova G, Upmanyu R, et al.
Eur Heart J
. 2014 Mar;
35(27):1792-800.
PMID: 24639426
Aims: The effects of cholesteryl ester transfer protein (CETP) inhibition on lipids, inflammation, and markers of high-density lipoprotein (HDL) function, following an acute coronary syndrome (ACS), are unknown. Methods And...
5.
Mohler H, Boison D, Singer P, Feldon J, Pauly-Evers M, Yee B
Biochem Pharmacol
. 2011 Feb;
81(9):1065-77.
PMID: 21333635
Schizophrenia is characterized by positive symptoms such as hallucinations, negative symptoms such as blunted affect, and symptoms of cognitive deficiency such as deficits in working memory and selective attention. N-methyl-d-aspartate...
6.
Nordquist R, Ballard T, Algeyer B, Pauly-Evers M, Ozmen L, Spooren W
Neuropharmacology
. 2009 Jun;
58(1):259-67.
PMID: 19540857
The tachykinin NK(3) receptor shows promise as a novel target for antipsychotics, but knowledge of downstream activity following tachykinin NK(3) receptor activation is lacking. To determine the practical utility of...
7.
Nordquist R, Savignac H, Pauly-Evers M, Walker G, Knoflach F, Borroni E, et al.
Behav Pharmacol
. 2008 Aug;
19(5-6):518-29.
PMID: 18690106
The neurokinin 3 (NK3) receptor is a novel target under investigation for improvement of symptoms of schizophrenia, because of its ability to modulate dopaminergic signaling. To further understanding of the...
8.
Gabernet L, Pauly-Evers M, Schwerdel C, Lentz M, Bluethmann H, Vogt K, et al.
Neurosci Lett
. 2004 Nov;
373(1):79-84.
PMID: 15555781
The occupation of the glycine binding-site is a prerequisite for NMDA receptor activation by glutamate. To analyze the regulation of NMDA receptor function by the glycine transporter 1 (GlyT1), we...
9.
Ballard T, Pauly-Evers M, Higgins G, Ouagazzal A, Mutel V, Borroni E, et al.
J Neurosci
. 2002 Aug;
22(15):6713-23.
PMID: 12151550
NMDA receptor hypofunction has been implicated in the pathophysiology of schizophrenia, and pharmacological and genetic approaches have been used to model such dysfunction. We previously have described two mouse lines...